ACE-031 and Anastrozole Interaction

Synergistic
Mechanism-based 46% confidence

ACE-031 and Anastrozole have a synergistic interaction with 46% confidence. Anastrozole supports hormonal recovery from suppression caused by ACE-031. Standard protocol — begin PCT after the suppressive compound has cleared based on its half-life. Both compounds affect the gonads and heart and liver and pituitary, so monitoring these systems is recommended.

Compound Profiles

ACE-031

Myostatin Inhibitor | Experimental Muscle Growth

ACE-031 acts as a ligand trap for members of the TGF-beta superfamily. By mimicking the extracellular domain of the ActRIIB receptor, it intercepts myostatin (GDF-8), activin A, activin B, and GDF-11 before they can bind cell-surface receptors and activate Smad2/3 signaling.

Half-life: 12-15 days Typical dose: 0.5-3 mg/kg IV every 2 weeks (clinical research doses only) growth hormone, anabolic
actriibmyostatintgf beta androgenicanticoagulantblood pressure raisinghpta suppressive
View full profile

Anastrozole

Aromatase Inhibitor | Estrogen Management

Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.

Half-life: ~40-50 hours Typical dose: 0.25-0.5mg EOD or E3D (estrogen management) pct, anabolic
aromatase androgenicaromatase inhibitorestrogenichepatotoxic
View full profile

Combined Organ Load

Gonads
elevated
Heart
moderate
Liver
moderate
Pituitary
low

Shared Safety Flags

2x 2 androgenic compounds (ACE-031, Anastrozole). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 HPTA-suppressive compounds (ACE-031, Anastrozole). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (ACE-031, Anastrozole). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (ACE-031, Anastrozole). Monitor accordingly.

Frequently Asked Questions

Can I take ACE-031 with Anastrozole?

Yes, ACE-031 and Anastrozole can generally be taken together. Anastrozole supports hormonal recovery from suppression caused by ACE-031. Standard protocol — begin PCT after the suppressive compound has cleared based on its half-life.

Is ACE-031 and Anastrozole safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: androgenic, hpta suppressive, lipid disrupting, teratogenic. Monitor accordingly.

What are the interactions between ACE-031 and Anastrozole?

Anastrozole supports hormonal recovery from suppression caused by ACE-031. Standard protocol — begin PCT after the suppressive compound has cleared based on its half-life. This assessment has 46% confidence and is inferred from pharmacological mechanism analysis.

How should I time ACE-031 and Anastrozole?

ACE-031 has a half-life of 12-15 days and Anastrozole has a half-life of ~40-50 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: ACE-031 vs Anastrozole

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.